Intravenous streptokinase for myocardial infarction: a reanalysis of the historical cumulative evidence using Trial Sequential Analysis

Kim Boesen, Christian Gluud
doi: https://doi.org/10.1101/2024.09.24.24314267

Article Information

doi 
https://doi.org/10.1101/2024.09.24.24314267
History 
  • September 24, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Kim Boesen1,* and
  2. Christian Gluud1,2
  1. 1Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark
  2. 2Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
  1. ↵*Corresponding author
    Kim Boesen, MD, PhD kim.boesen{at}ctu.dk
Back to top
Posted September 24, 2024.
Download PDF
Data/Code
Email
Intravenous streptokinase for myocardial infarction: a reanalysis of the historical cumulative evidence using Trial Sequential Analysis
Kim Boesen, Christian Gluud
medRxiv 2024.09.24.24314267; doi: https://doi.org/10.1101/2024.09.24.24314267
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area